trial · primary record
Sonication for opening of blood-brain barrier
Glioblastoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 57 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Dose limiting toxicity (Phase1) |
| Registry ID | NCT04528680 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:07.761Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04528680
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.